ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

ANIX Anixa Biosciences Inc

2,9619
-0,0581 (-1,92%)
Dernière mise à jour : 18:19:07
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Anixa Biosciences Inc ANIX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0581 -1,92% 2,9619 18:19:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,03 2,915 3,086 3,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202413:45PRNUSAnixa Biosciences to Participate in the Sidoti Micro-Cap..
18/4/202414:20PRNUSAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay..
14/3/202413:45PRNUSAnixa Biosciences 2024 Annual Meeting of Stockholders to..
11/3/202413:00PRNUSAnixa Biosciences Announces Presentation at 24th Annual..
12/2/202413:30PRNUSAnixa Biosciences Initiates Dosing in Second Cohort of..
08/2/202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202414:50PRNUSAnixa Biosciences Announces Participation in 2024..
23/1/202413:55PRNUSAnixa Biosciences Announces Japanese Patent on Ovarian..
17/1/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:29EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202422:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/1/202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
10/1/202415:00PRNUSAnixa Biosciences to Present at Sidoti Micro-Cap Virtual..
14/12/202313:15PRNUSAnixa Biosciences to Present at Biotech Showcase 2024
07/12/202312:01EDGAR2Form 8-K - Current report
07/12/202300:00PRNUSAnixa Biosciences and Cleveland Clinic Present Positive New..
06/12/202322:05PRNUSAnixa Biosciences to Host Conference Call This Evening to..
27/11/202314:30PRNUSAnixa Biosciences Announces European Patent on Ovarian..
02/11/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202313:30PRNUSAnixa Biosciences to Present at the Ovarian Cancer Research..
23/10/202314:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
13/10/202314:30PRNUSAnixa Biosciences Completes Treatment of First Patient..
11/10/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202314:30PRNUSAnixa Biosciences Announces Issuance of Additional U.S...
19/9/202314:30PRNUSAnixa Biosciences Establishes Cancer Business Advisory Board
06/9/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/8/202314:30PRNUSAnixa Biosciences to Participate in September Investor..
28/8/202314:30PRNUSAnixa Biosciences Announces Treatment of Third Patient in..
14/8/202314:30PRNUSAnixa Biosciences Announces Invited Presentation on Ovarian..
07/8/202314:30PRNUSAnixa Biosciences Announces Opening of Enrollment for..
01/8/202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202300:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202314:30PRNUSAnixa Biosciences Announces Notice of Allowance of..
21/7/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202314:30PRNUSAnixa Biosciences Announces Issuance of Canadian Patent for..
22/5/202314:30PRNUSAnixa Biosciences Announces Treatment of Second Patient in..

Dernières Valeurs Consultées

Delayed Upgrade Clock